Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,501 | -11,907 | -8,879 | -5,822 | -3,325 |
| Depreciation Amortization | 22 | 82 | 61 | 32 | 16 |
| Accounts receivable | 48 | -54 | -153 | -64 | -179 |
| Other Working Capital | 562 | -214 | 132 | -535 | 6 |
| Other Operating Activity | 309 | 1,532 | 1,275 | 831 | 569 |
| Operating Cash Flow | $-2,560 | $-10,561 | $-7,564 | $-5,558 | $-2,913 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -70 | -68 | -54 | -29 |
| Investing Cash Flow | $-10 | $-70 | $-68 | $-54 | $-29 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 244 | 5,540 | 1,658 | 1,519 | N/A |
| Other Financing Activity | -180 | -418 | -231 | -165 | 0 |
| Financing Cash Flow | $64 | $5,122 | $1,427 | $1,354 | $N/A |
| Beginning Cash Position | 7,363 | 12,872 | 12,872 | 12,872 | 12,872 |
| End Cash Position | 4,857 | 7,363 | 6,667 | 8,614 | 9,930 |
| Net Cash Flow | $-2,506 | $-5,509 | $-6,205 | $-4,258 | $-2,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,560 | -10,561 | -7,564 | -5,558 | -2,913 |
| Capital Expenditure | -10 | -70 | -68 | -54 | -29 |
| Free Cash Flow | -2,570 | -10,631 | -7,632 | -5,612 | -2,942 |